Mr Pavithran Ayyala, Head Digital Services & CIO, Utthunga Technologies
Bengaluru Pharma Summit 2024 | 21st June 2024 | Welcomhotel by ITC, Bengaluru
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Mr Loganathan S, AVP (Device Development & Packaging), Stelis Biopharma
Bengaluru Pharma Summit 2024 | 21st June 2024 | Welcomhotel by ITC, Bengaluru
FDA approves Genentech’s Vabysmo Prefilled Syringe (PFS) for three leading causes of vision loss
Vabysmo PFS is reportedly the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal…
Mr Krishnendu Roy, Sales Leader AI – India & Subcontinent, Veolia Water Technologies…
Bengaluru Pharma Summit 2024 | 21st June 2024 | Welcomhotel by ITC, Bengaluru
Dr Anil Kumar R, Sr VP – R&D & MSAT, Strides Pharma
Bengaluru Pharma Summit 2024 | 21st June 2024 | Welcomhotel by ITC, Bengaluru
Mr Spandan Silvester Athaide, Technical Lead, Central Solutions Enterprise
Bengaluru Pharma Summit 2024 | 21st June 2024 | Welcomhotel by ITC, Bengaluru
Panel Discussion: Navigating India Pharma Inc’s challenges and opportunities
Bengaluru Pharma Summit 2024 | 21st June 2024 | Welcomhotel by ITC, Bengaluru
AstraZeneca plans to invest Rs 250 crore to grow its Global Innovation and Technology Centre in…
The investment marks a significant milestone in AstraZeneca’s growth story in India as it celebrates its 45 year in the country…
Alembic Pharma announces US FDA tentative approval for Ivosidenib tablets 250 mg
The approved ANDA is therapeutically equivalent to the RLD product, Tibsovo Tablets, 250 mg, of Servier Pharmaceuticals
Submission of Nidlegy marketing authorisation application validated by EMA
The first marketing authorisation application of Nidlegy for the treatment of locally advanced fully resectable melanoma was…